SEOVF — SERNOVA CORP.
—
OTC ·
Unknown ·
Unknown ·
CIK 1491434 ·
Last close
$0.11
Market Cap
$37.83M
52W High
$0.14
52W Low
$0.10
ADV30
24,803
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jan 2026 | 0 | — | -2,115,020 | -2,334,402 | 1,012,821 | 576,221 | 26,614,968 |
| Oct 2025 | 0 | — | -2,396,204 | -2,197,203 | 764,234 | 265,004 | 25,841,064 |
| Jul 2025 | 0 | — | -3,499,897 | -4,073,783 | 910,719 | 83,617 | 25,343,166 |
| Apr 2025 | 0 | — | -4,326,662 | -3,777,163 | 3,873,591 | 1,997,707 | 24,534,447 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,127,770
Investing CF
$24,958
Financing CF
$6,471,469
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.05
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-168,437,010
Inventory
—
Receivables
$125,587
ST Investments
$0
EBIT TTM
$-11,454,567
Pretax Income TTM
$-12,451,519
Interest Exp TTM
$996,952
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 0 | -15,023,024 | -15,743,466 | 764,234 | 25,841,064 | — | -10,907,967 |
| Oct 2024 | 0 | -31,663,742 | -32,192,135 | 7,527,339 | 20,483,947 | — | -18,896,313 |
| Oct 2023 | 0 | -40,501,593 | -38,997,520 | 22,106,815 | 9,592,280 | — | -30,339,117 |
| Oct 2022 | 0 | -24,753,761 | -24,420,536 | 52,484,921 | 4,876,256 | — | -14,421,398 |
| Oct 2021 | — | — | — | — | — | — | — |
News headlines (Yahoo Finance, 1h cache)
Sernova Biotherapeutics Announces Closing of Recently Approved Financings
2026-04-23 20:15 · Yahoo
Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders
2026-04-09 11:00 · Yahoo
Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing
2026-03-24 11:00 · Yahoo
Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
2026-03-04 12:00 · Yahoo
Sernova Biotherapeutics Announces Warrant Amendments
2026-02-20 12:00 · Yahoo
Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts
2025-11-13 12:00 · Yahoo
Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang
2025-10-01 11:00 · Yahoo
Loss-Making Sernova Biotherapeutics Inc (TSE:SVA) Expected To Breakeven In The Medium-Term
2025-08-30 13:49 · Yahoo
Sernova Partners With Eledon Pharmaceuticals to Advance Potential Functional Cure for Type 1 Diabetes
2025-07-09 14:48 · Yahoo
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
2025-07-09 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.